Mitoxantrone Hydrochloride (Pfizer Laboratories Div Pfizer Inc.)


Welcome to the PulseAid listing for the Mitoxantrone Hydrochloride drug offered from Pfizer Laboratories Div Pfizer Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pfizer Laboratories Div Pfizer Inc.
NON-PROPRIETARY NAME: Mitoxantrone Hydrochloride
SUBSTANCE NAME: MITOXANTRONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-12-12
END MARKETING DATE: 0000-00-00


Mitoxantrone Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMitoxantrone Hydrochloride from Pfizer Laboratories Div Pfizer Inc.
LABELER NAME: Pfizer Laboratories Div Pfizer Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2012-12-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0069-0080_5815a273-349f-4a9b-b6fd-af44958ba67c
PRODUCT NDC: 0069-0080
APPLICATION NUMBER: ANDA201014

Other MITOXANTRONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCMitoxantrone
Hospira, Inc.Mitoxantrone
Pfizer Laboratories Div Pfizer Inc.Mitoxantrone Hydrochloride
Teva Parenteral Medicines, Inc.mitoXANTRONE